UCSF Launches Artificial Intelligence Center to Advance Medical Imaging
UCSF is launching a new center to accelerate the application of AI technology to radiology.
University of California San Francisco
Give to UCSFUCSF is launching a new center to accelerate the application of AI technology to radiology.
Tens of thousands of Americans suffer pneumothorax each year, a potentially life-threatening condition that is sometimes overlooked in busy emergency rooms.
UCSF scientists have for the first time decoded spoken words and phrases in real time from the brain signals that control speech.
Researchers devised “smart” cells that behave like tiny autonomous robots which may be used to detect damage and disease, and deliver help at just the right time and in just the right amount.
For months, the 78-year-old had been behaving strangely. Fearing the worst, his family consulted UCSF neurologist Georges Naasan, MD.
Every day, California’s Poison Hotline responds to over 700 calls from those needing to know whether a substance is toxic. Whether it’s hand sanitizer, glow sticks, pills, or worse, UCSF operators are on hand to help determine if it’s an actual medical emergency.
The intervention, an app called MediTrain, uses a closed-loop algorithm that tailors the length of meditation sessions to the abilities of the participants.
Chuang and Keiser have shown how machine learning could lead scientists astray and how scientists might, in the future, avoid some of the pitfalls of training computers to be scientists.
The technology could one day restore the voices of people who have lost the ability to speak due to paralysis and other forms of neurological damage.
UCSF researchers have created a proof-of-concept method for ensuring the integrity of clinical trials data with blockchain.
The Health Innovation Via Engineering program will be led by Tejal Desai.
UCSF researchers programmed a machine-learning algorithm to diagnose early-stage Alzheimer’s disease. The algorithm used PET scans – a common type of brain scan.
After Matthew Wetschler broke his neck body surfing, he became the first person to undergo a new protocol –pioneered by a UCSF surgeon – for treating spinal cord injuries.
A growing number of researchers at UCSF and elsewhere have turned their attention to questions around why and how some people who age thrive and are more resilient than others.
UCSF experts share their science-backed strategies for aging well.
Scientists at UCSF have developed an innovative tool to peer into the secret life of brain. They hope to use the device to learn more about how memories form, and how past experiences influence decisions.
Technology is giving UCSF doctors new tools to customize care for patients, and the health care practitioners of the future are learning how to implement the technology through a new course.
The ascendancy of CRISPR systems raises a grand hope: If these tools can illuminate the causes of disease in the laboratory, why not bring them into the clinic to treat patients?
Scientists at UCSF have assembled a searchable database of normal human immunity that researchers can now use as an instant comparison group in studies of the immune system and immune dysfunction.
UCSF’s Shuvo Roy has spent the better part of a decade working on technology that could lead to a a surgically implantable bioartificial kidney. Now he is also working with UCSF colleagues to turn that technology into an artificial pancreas.
Thanks to a $6.7 million grant, the newly named UCSF-Stanford Pediatric Device Consortium can focus on the development of revolutionary, low-cost gadgets to diagnose and cure pediatric health conditions.
By creating a tailored drug cocktail that matches the mutations of a brain tumor, a new precision medicine approach may move the needle for children with high-grade gliomas.
Insights into pitch control could pave the way for advanced brain prosthetics that could allow people who can’t speak to express themselves in a naturalistic way.
Sensory Processing Disorder, or SPD, causes some children to find everyday stimuli excruciating. Scientists are finally shedding light on what causes the disorder and what can be done about it.
UCSF researchers have identified a key biological pathway in human cancer patients that appears to prime the immune system for a successful response to immunotherapy drugs – checkpoint inhibitors.
Silicon Valley is helping researchers like Wendell Lim move basic science breakthroughs into translational applications, making treatments available to patients faster than normally possible.
The journey from discovering and developing effective, precise medications to using them correctly and safely in patients is hardly fast and easy. Nor is it a straight shot. Scientists in the UCSF School of Pharmacy are challenging the status quo every step of the way.
An easy-to-use implant sensor for at-home glaucoma monitoring developed by researchers at Caltech and tested at UCSF could significantly benefit patients by providing convenient, on-demand self-monitoring and physicians by more effectively tailoring individual treatments.
In the absence of rigorous preclinical testing from the FDA, health systems should carefully scrutinize digital tools that interact with electronic health records to recommend patient diagnoses or therapies.